Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study.

Parkash R, Thibault B, Sterns L, Sapp J, Krahn A, Talajic M, Luce M, Yetisir E, Theoret-Patrick P, Wells G, Tang A.

Circulation. 2012 Dec 18;126(25):2928-34. doi: 10.1161/CIRCULATIONAHA.112.132100. Epub 2012 Nov 16.

2.

Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).

Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS; RAFT Investigators.

Circ Heart Fail. 2012 Sep 1;5(5):566-70. Epub 2012 Aug 14.

3.

Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.

Essebag V, Joza J, Birnie DH, Sapp JL, Sterns LD, Philippon F, Yee R, Crystal E, Kus T, Rinne C, Healey JS, Sami M, Thibault B, Exner DV, Coutu B, Simpson CS, Wulffhart Z, Yetisir E, Wells G, Tang AS.

Circ Arrhythm Electrophysiol. 2015 Feb;8(1):152-8. doi: 10.1161/CIRCEP.114.001997. Epub 2014 Nov 23.

4.

Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.

Gillis AM, Kerr CR, Philippon F, Newton G, Talajic M, Froeschl M, Froeschl S, Swiggum E, Yetisir E, Wells GA, Tang AS.

Circulation. 2014 May 20;129(20):2021-30. doi: 10.1161/CIRCULATIONAHA.112.000417. Epub 2014 Mar 7.

5.

Lower incidence of inappropriate shock therapy in patients with combined cardiac resynchronisation therapy defibrillators (CRT-D) compared with patients with non-CRT defibrillators (ICDs).

Chen Z, Kotecha T, Crichton S, Shetty A, Sohal M, Arujuna A, Kirubakaran S, Bostock J, Cooklin M, O'Neill M, Wright M, Gill JS, Rinaldi CA.

Int J Clin Pract. 2013 Aug;67(8):733-9. doi: 10.1111/ijcp.12033.

PMID:
23869676
6.

Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.

Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT.

Heart Rhythm. 2007 Jul;4(7):892-6. Epub 2007 Apr 10.

PMID:
17599673
7.

Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.

Hauser RG, Hayes DL.

Heart Rhythm. 2009 May;6(5):605-10. doi: 10.1016/j.hrthm.2009.02.024. Epub 2009 Feb 20.

PMID:
19285920
8.

Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.

Ellis CR, Rottman JN.

Heart Rhythm. 2009 May;6(5):619-24. doi: 10.1016/j.hrthm.2009.02.020. Epub 2009 Feb 14.

PMID:
19389648
9.

Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.

Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer MA, Moss AJ; MADIT-CRT Investigators.

Circulation. 2010 Sep 7;122(10):985-92. doi: 10.1161/CIRCULATIONAHA.110.955039. Epub 2010 Aug 23.

10.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators.

N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.

11.

Update on small-diameter implantable cardioverter-defibrillator leads performance.

van Rees JB, van Welsenes GH, Borleffs CJ, Thijssen J, van der Velde ET, van der Wall EE, van Erven L, Schalij MJ.

Pacing Clin Electrophysiol. 2012 Jun;35(6):652-8. doi: 10.1111/j.1540-8159.2011.03338.x. Epub 2012 Feb 21.

PMID:
22352338
12.

Cardiac-resynchronization therapy for the prevention of heart-failure events.

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators.

N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.

13.

Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.

Alam MB, Munir MB, Rattan R, Flanigan S, Adelstein E, Jain S, Saba S.

Europace. 2014 Feb;16(2):246-51. doi: 10.1093/europace/eut301. Epub 2013 Oct 6.

14.

Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.

Girerd N, Nonin E, Pinot J, Morel E, Flys C, Scridon A, Chevalier P.

Arch Cardiovasc Dis. 2011 Jun-Jul;104(6-7):388-95. doi: 10.1016/j.acvd.2011.05.002. Epub 2011 Jul 8.

15.
16.

A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model.

Bashir J, Cowan S, Raymakers A, Yamashita M, Danter M, Krahn A, Lynd LD.

Heart Rhythm. 2013 Dec;10(12):1761-7. doi: 10.1016/j.hrthm.2013.09.067. Epub 2013 Sep 25.

PMID:
24076445
17.

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality.

Theuns DA, Schaer BA, Soliman OI, Altmann D, Sticherling C, Geleijnse ML, Osswald S, Jordaens L.

Europace. 2011 Jan;13(1):62-9. doi: 10.1093/europace/euq328. Epub 2010 Sep 10.

18.

Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial.

Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, Goldenberg I, Huang DT, Merkely B, Wang PJ, Moss AJ, Klein H.

Eur Heart J. 2013 Jan;34(3):184-90. doi: 10.1093/eurheartj/ehs334. Epub 2012 Oct 10.

19.

Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.

Foo D, Walker BD, Kuchar DL, Thorburn CW, Tay A, Hayward CS, Macdonald P, Keogh A, Kotlyar E, Spratt P, Jansz P.

Pacing Clin Electrophysiol. 2009 Jul;32(7):879-87. doi: 10.1111/j.1540-8159.2009.02403.x.

PMID:
19572863
20.

Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.

Lovelock JD, Patel A, Mengistu A, Hoskins M, El-Chami M, Lloyd MS, Leon A, DeLurgio D, Langberg JJ.

Heart Rhythm. 2012 Oct;9(10):1615-8. doi: 10.1016/j.hrthm.2012.06.009. Epub 2012 Jun 6.

PMID:
22683747
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk